ACIP 循证推荐制定框架更新
美国免疫实践咨询委员会(ACIP)是向 CDC 主任及美国卫生与公众服务部部长提供疫苗使用建议的联邦咨询委员会。本报告简要总结了 ACIP 于 2018 年 2 月会议通过的循证推荐制定流程更新。
要点
- ACIP 推荐经投票成员多数通过后由 CDC 主任审核并在 MMWR 发表。
- 工作组负责收集、分析科学信息并基于评估证据提出推荐选项。
- 2018 年 2 月 ACIP 会议通过了循证推荐制定流程的更新。
核心结论
- ACIP 更新了其制定循证推荐意见的流程,该更新在 2018 年 2 月会议上获得通过。
研究设计与样本
- 本文为对 ACIP 循证推荐制定流程更新的简要总结,未报告系统检索或原始研究数据。
主要发现
- ACIP 是向 CDC 主任和美国卫生与公众服务部部长提供疫苗及相关制剂使用建议的联邦咨询委员会。
- 工作组收集、分析并准备科学信息,基于所评估的科学证据提出推荐选项。
- 推荐经 ACIP 投票成员多数批准后,由 CDC 主任审核,获批后在 MMWR 发表。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Advisory Committee on Immunization Practices (ACIP)* is a federal advisory committee that provides expert advice to the Director of CDC and the Secretary of the U.S. Department of Health and Human Services in the form of recommendations on the use of vaccines and related agents for control of vaccine-preventable diseases in the U.S. civilian population (1,2). Work groups that gather, analyze, and prepare scientific information assist in the recommendation formulation process and present options for recommendations based on the scientific evidence they have assessed. Recommendations that are approved by a majority of ACIP's voting members are then reviewed by the Director of CDC and published in MMWR if approved by the director. This report briefly summarizes an update to the ACIP process for developing evidence-based recommendations that ACIP adopted at its February 2018 meeting.
引用
- Lee G, Carr W. Updated Framework for Development of Evidence-Based Recommendations by the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2018. PMID: 30439877. doi:10.15585/mmwr.mm6745a4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。